ANTI-TIRC7 ANTIBODIES IN THERAPY OF INFLAMMATORY DISEASES

Details for Australian Patent Application No. 2002366746 (hide)

International Classifications

Event Publications

28 August 2003 Complete Application Filed

Priority application(s): 01130730.3 21.12.01 EP; 02013261.9 17.06.02 EP; 02018809.0 22.08.02 EP

2 October 2003 Application Open to Public Inspection

Published as AU-A-2002366746

16 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

20 January 2005 Section 223 Application Received

GENPAT77 PHARMACOGENETICS AG An application to extend the time from 21 Jul 2004 to 21 Nov 2004 in which to enter the national phase has been filed . Address for service in Australia - Cullen & Co Level 26, 239 George Street Brisbane QLD 4000 2004

17 March 2005 Section 223 Application Allowed

GENPAT77 PHARMACOGENETICS AG The time in which to enter the national phase has been extended to 21 Nov 2004. Address for service in Australia - Cullen & Co Level 26, 239 George Street Brisbane QLD 4000 2003

17 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.